Last updated on July 2017

Phase 3, Randomized, Open-label, Active-controlled Study Evaluating the Efficacy and Safety of Oral Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD) (PRO2TECT-CONVERSION).


Brief description of study

Phase 3, Randomized, Open-label, Active-controlled Study Evaluating the Efficacy and Safety of Oral Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD) (PRO2TECT-CONVERSION).

Detailed Study Description

A Multicenter, Randomized, Open-label, active-controlled Phase 3 study for the maintenance treatment of anemia in subjects with NDD-CKD

Qualified Participants will receive at no cost to them.

  • Study Medication
  • Study Related Labs
  • Physical Exams
  • Rescue Medication
  • Compensation for your time and travel for each completed study visit

    To Lean More about this study and other Chronic Kidney Disease ( CKD) for Non- Dialysis ( NDD) - including Dialysis Dependent ( DD), with or with out Anemia , please go to our contact information below.

    Clinical Study Identifier: TX150858

    Contact Investigators or Research Sites near you

    Start Over

    Roxy

    West Broward Research Institute, LLC
    Lauderdale Lakes, FL USA
      Connect »